tiprankstipranks
Trending News
More News >
Nature's Sunshine Products (NATR)
NASDAQ:NATR
US Market

Nature's Sunshine Products (NATR) AI Stock Analysis

Compare
155 Followers

Top Page

NA

Nature's Sunshine Products

(NASDAQ:NATR)

77Outperform
Nature's Sunshine Products displays strong financial health, robust cash flow, and a stable balance sheet, contributing to a solid foundation in the packaged foods industry. The stock exhibits positive technical momentum, although it's nearing overbought levels. Valuation is less attractive due to a high P/E ratio and no dividend yield, but recent earnings results and strategic expansion efforts in key markets provide reasons for optimism. Challenges in North America and macroeconomic uncertainties are noted, but overall, the stock is well-positioned for future growth.
Positive Factors
Digital Sales Growth
The digital channel continued to see strong results with sales up +19%.
Gross Margin
Gross margin increased to 72.1%, driven by price increases and cost-saving initiatives.
Share Repurchase
A $25M share repurchase authorization underscores Board confidence.
Negative Factors
North American Sales
In North America, sales were down slightly due to weaker-than-anticipated customer activations.
Tariff Impact
Tariffs could potentially have a $2-3M headwind to gross margin in FY25.

Nature's Sunshine Products (NATR) vs. S&P 500 (SPY)

Nature's Sunshine Products Business Overview & Revenue Model

Company DescriptionNature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.
How the Company Makes MoneyNature's Sunshine Products generates revenue primarily through the sale of its nutritional and personal care products. The company employs a multi-channel distribution strategy, which includes direct sales through a network of independent distributors and direct-to-consumer sales via e-commerce platforms. This diversified approach allows the company to reach a broad customer base both domestically and internationally. Additionally, Nature's Sunshine has established strategic partnerships and alliances to enhance its market presence and expand its product offerings. The company's focus on quality and efficacy contributes to brand loyalty and repeat purchases, which are significant drivers of its revenue.

Nature's Sunshine Products Financial Statement Overview

Summary
Nature's Sunshine Products exhibits solid financial health characterized by steady revenue growth, strong cash flow generation, and a stable balance sheet. While profitability metrics show room for enhancement, the company's low debt levels and efficient cash management provide a strong foundation for future growth. The consistent performance across financial statements demonstrates resilient operations in the packaged foods industry.
Income Statement
75
Positive
Nature's Sunshine Products shows strong financial performance with consistent revenue growth and profitability. The TTM revenue growth rate of 0.50% indicates a steady increase in sales compared to the previous year. The gross profit margin remains robust at 71.67%, while the net profit margin improved slightly to 2.22%. Both EBIT and EBITDA margins are healthy at 4.74% and 7.46%, respectively, demonstrating efficient operations. However, the net profit margin is relatively low, suggesting room for improvement in cost management.
Balance Sheet
70
Positive
The company's balance sheet is stable with a low debt-to-equity ratio of 0.09, indicating minimal reliance on debt financing. Return on equity (ROE) is modest at 6.28%, reflecting moderate profitability relative to shareholder equity. The equity ratio is strong at 63.84%, signifying solid financial positioning and low leverage. Although the balance sheet is healthy, the growth in equity is gradual, indicating potential for further strengthening.
Cash Flow
80
Positive
Cash flow metrics for Nature's Sunshine Products are strong, with a significant free cash flow growth rate of 20.92%. The operating cash flow to net income ratio is 2.54, highlighting efficient cash generation relative to earnings. Additionally, the free cash flow to net income ratio of 1.71 indicates robust cash flow management, allowing for potential reinvestment or dividend distributions. The cash position is well-managed, contributing to financial flexibility.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
456.62M454.36M445.32M421.91M444.08M385.20M
Gross Profit
327.31M324.69M321.13M299.76M328.62M283.93M
EBIT
21.64M20.09M18.75M16.26M34.67M21.48M
EBITDA
34.06M32.79M32.09M27.28M45.83M32.23M
Net Income Common Stockholders
10.12M7.70M15.08M550.00K28.85M21.34M
Balance SheetCash, Cash Equivalents and Short-Term Investments
86.49M84.70M82.37M60.03M86.18M92.07M
Total Assets
252.70M240.85M249.77M229.78M258.87M249.50M
Total Debt
14.85M14.20M14.92M19.18M22.99M26.33M
Net Debt
-71.64M-70.50M-67.45M-40.85M-63.20M-65.74M
Total Liabilities
85.60M79.86M90.23M82.73M97.47M92.26M
Stockholders Equity
161.28M155.31M154.06M142.91M158.20M155.39M
Cash FlowFree Cash Flow
17.32M14.33M30.75M-6.92M27.94M32.75M
Operating Cash Flow
25.72M25.30M41.23M710.00K34.61M37.66M
Investing Cash Flow
-8.39M-10.97M-10.48M-7.63M-6.61M-4.91M
Financing Cash Flow
-10.74M-9.90M-7.96M-16.25M-31.72M3.88M

Nature's Sunshine Products Technical Analysis

Technical Analysis Sentiment
Positive
Last Price14.88
Price Trends
50DMA
12.74
Positive
100DMA
13.61
Positive
200DMA
13.90
Positive
Market Momentum
MACD
0.66
Negative
RSI
71.89
Negative
STOCH
78.58
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NATR, the sentiment is Positive. The current price of 14.88 is above the 20-day moving average (MA) of 13.04, above the 50-day MA of 12.74, and above the 200-day MA of 13.90, indicating a bullish trend. The MACD of 0.66 indicates Negative momentum. The RSI at 71.89 is Negative, neither overbought nor oversold. The STOCH value of 78.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NATR.

Nature's Sunshine Products Risk Analysis

Nature's Sunshine Products disclosed 25 risk factors in its most recent earnings report. Nature's Sunshine Products reported the most risks in the “Legal & Regulatory” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Nature's Sunshine Products Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
$272.88M27.786.42%2.00%-37.09%
70
Outperform
$168.56M19.1830.11%1.19%8.22%159.71%
69
Neutral
$257.53M72.9516.69%19.41%-43.88%
66
Neutral
$129.50M15.1925.89%9.14%18.87%
64
Neutral
$8.82B14.704.78%173.90%3.26%2.11%
LSLSF
58
Neutral
$72.61M-7.38%25.04%87.51%
43
Neutral
$177.80M-31.83%-8.50%-186.18%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NATR
Nature's Sunshine Products
14.88
-0.20
-1.33%
HAIN
Hain Celestial
2.07
-5.20
-71.53%
LFVN
LifeVantage
13.18
6.10
86.16%
FTLF
FitLife Brands
13.79
-0.09
-0.65%
MAMA
Mama's Creations
6.93
0.00
0.00%
LSF
Laird Superfood
6.87
4.35
172.62%

Nature's Sunshine Products Earnings Call Summary

Earnings Call Date:May 06, 2025
(Q1-2025)
|
% Change Since: 19.90%|
Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment Positive
The earnings call presented a strong start to 2025 with growth in key markets and improved profitability. However, challenges in North America and uncertainties related to tariffs and macroeconomic conditions were noted.
Q1-2025 Updates
Positive Updates
Strong Start to 2025
First quarter results beat analyst expectations with revenue at $113 million or $115 million on a constant currency basis, up 5% versus prior year. Adjusted EBITDA was also strong, at $11 million, up 20% versus prior year.
Asia Pacific and Europe Growth
Revenue in Asia Pacific increased 10% versus prior year on a local currency basis, with Japan and Taiwan sales increasing 24% and 18%, respectively. Sales in Europe increased 9% on a constant currency basis, driven by a 16% increase in Central Europe.
Digital Sales Expansion
Digital sales in North America increased 19% versus prior year, more than double the supplement industry's digital growth rate, with the Subscribe & Thrive autoship program representing approximately 26% of total sales.
Sustainability Achievements
Achievements include a 50% reduction in carbon emissions and a 35% cut in waste, along with 100% solar power utilization at the manufacturing facility.
Improved Profitability
Operating income increased to $6.2 million compared to $4.6 million in the year-ago quarter, and GAAP net income was $4.7 million compared to $2.3 million.
Strong Balance Sheet
The company has $86.5 million in cash and cash equivalents, zero debt, and has repurchased 38,000 shares with $33.3 million remaining for share repurchase.
Negative Updates
North America Sales Decline
Sales in North America declined 4% due to a difficult comparison with the prior year and increased macroeconomic uncertainty impacting consumer sentiment.
Tariff and Macroeconomic Uncertainty
The company is operating in an uncertain macroeconomic environment with evolving tariffs and potential impacts on consumer spending.
Company Guidance
In the first quarter of 2025, Nature's Sunshine reported strong financial performance, exceeding analyst expectations with revenue of $113 million, or $115 million on a constant currency basis, reflecting a 5% year-over-year increase. Adjusted EBITDA rose by 20% to $11 million. The company achieved notable growth in the Asia Pacific region, with sales up 10% locally, driven by Japan and Taiwan, which reported increases of 24% and 18% respectively. In Europe, sales grew 9% on a constant currency basis, with Central Europe seeing a 16% rise. Conversely, North America experienced a 4% sales decline but showed signs of recovery with digital sales up 19%. Nature's Sunshine maintained its guidance for 2025, projecting net sales between $445 million and $470 million and adjusted EBITDA between $38 million and $44 million, amid a challenging macroeconomic environment and potential tariff impacts.

Nature's Sunshine Products Corporate Events

Executive/Board ChangesShareholder Meetings
Nature’s Sunshine Products 2025 Shareholders Meeting Outcomes
Neutral
May 6, 2025

Nature’s Sunshine Products held its 2025 Annual Meeting of Shareholders on April 30, 2025, where shareholders voted on several key proposals. The shareholders elected all nominated directors, approved an advisory resolution on executive officer compensation, and ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2025.

Spark’s Take on NATR Stock

According to Spark, TipRanks’ AI Analyst, NATR is a Neutral.

Nature’s Sunshine Products receives a moderate overall stock score. While the company demonstrates robust profitability and strong market performance in Asia-Pacific and digital channels, it faces significant challenges with declining North America sales, increased SG&A expenses, and macroeconomic uncertainties. The stock’s technical indicators suggest bearish trends, and its high P/E ratio denotes overvaluation, which contributes to the overall cautious outlook.

To see Spark’s full report on NATR stock, click here.

Executive/Board Changes
Nature’s Sunshine Products Announces Executive Salary Increases
Neutral
Mar 11, 2025

On March 4, 2025, Nature’s Sunshine Products announced salary increases for key executives. The Chief Financial Officer, Mr. L. Shane Jones, received a salary increase from $460,000 to $478,400, and the Executive Vice President, Global Supply Chain, Mr. Martin Gonzalez, had his salary raised from $390,000 to $405,600. These adjustments reflect the company’s commitment to retaining top talent and may impact its operational costs.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.